Bronchiectasis clinical trials at UCSF

1 research study open to eligible people

Bronchiectasis is a lung disease where the airways get damaged and widened. UCSF is studying how support groups can help people with this condition feel better. Another trial looks at how these groups affect their overall health.

Showing trials for

  • Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis

    open to eligible people ages 18 years and up

    BronchConnect is a prospective trial to investigate the impact of support groups on health care related quality of life in those with noncystic fibrosis bronchiectasis (NCFBE). It has been well demonstrated that participation in patient support groups improves quality of life in those who suffer from interstitial lung disease and chronic obstructive pulmonary disease, but the impact is largely unknown for those who live with NCFBE, a chronic lung disease with rising prevalence with no targeted FDA-approved therapy. NCFBE causes chronic cough, dyspnea, recurrent infections, and leads to anxiety and uncertainty. This study seeks to evaluate the impact of a virtual patient support group for patients with NCFBE through questionnaires to assess change of quality of life and anxiety, and exacerbation rates through clinical assessment.

    San Francisco, California

Last updated: